You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》友芝友生物-B(02496.HK)公開發售下限定價16元 一手中籤率18%
阿思達克 09-22 08:44
友芝友生物-B(02496.HK)公佈招股結果,每股發售價定爲16元,爲招股價範圍(16至20元)下限定價。香港公開發售部分錄得超額認購約12.81倍。每手200股計,一手中籤率18%,要認購6,000股即30手才穩獲一手。該股將於下週一(25日)掛牌。獨家保薦人爲中信建投國際。 公司上市引入三名基石投資者,包括光谷健康、楚興友瑞及樸華凱智,合共認購651.38萬股公司股份,相當於緊隨全球發售完成後公司已發行股約3.38%。 該股上市料淨集資約1.21億元,當中約80%將用於公司的核心產品M701計劃進行的臨牀試驗、擬備註冊備案文件及商業化推出計劃(包括銷售和市場推廣活動);約12%將用於Y101D計劃進行的臨牀試驗;約8%將用作營運資金和一般公司用途。 友芝友生物爲致力於開發用於治療癌症相關併發症、癌症及老年性眼科疾病的雙特異性抗體(BsAb)療法的生物技術公司。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account